NFL and NFLPA Dispute Over Jalen Hurts’ Medical Care

During the NFL fall league meeting on Tuesday, officials addressed reporters to express satisfaction with how the Philadelphia Eagles managed quarterback Jalen Hurts’ blood clot issue. They criticized reports that drew incorrect conclusions about the situation.

A notable development occurred when the NFL Players Association (NFLPA) issued a statement later in the day. The union contested the league’s conclusions about Hurts’ care. They stated the league informed them no review of Hurts’ medical care would be conducted.

This raises questions about the NFL’s defense of the Eagles. The absence of a thorough review calls into question the NFL’s credibility in defending the Eagles’ handling of the matter.

“I’ll just sum it up by saying that I have complete confidence in the Eagles medical staff and their handling of this situation,” said Dr. Allen Sills, the NFL’s chief medical officer. He described their work as conservative, patient-focused, and appropriately guarded.

Sills shared that players like Hurts, who suffered deep vein thrombosis, occur in low numbers over a decade. He emphasized vigilance and prompt diagnosis in Hurts’ case, highlighting advanced imaging techniques used for diagnosis.

Sills assured that all aspects, from timing to decision-making, were approached with caution. Procedures such as diagnostic tests were performed with state-of-the-art imaging in London, displaying a high degree of suspicion to address issues quickly.

The NFL’s executive vice president of communications, Jeff Miller, clarified the league’s approach. He said they had spoken with Eagles staff, tracked the case, and consulted with hospitals and doctors involved. This was meant to ensure a comprehensive understanding of the events.

However, the NFLPA stated it was unaware of any NFL investigation into Hurts’ medical care. They reiterated previously receiving word from the league that no review was planned.

The conflicting statements raise questions on how the NFL could confidently assert the adequacy of Hurts’ care without reviewing the facts.

In response, the NFLPA emphasized the need for a full investigation before drawing conclusions. This, they argued, is vital to guarantee players receive optimal care and protection in the future.